Abstract
Obesity is an emerging epidemic in Canada that poses a threat to public health. Pharmaceutical weight management is an option for managing excess weight. In this review, we briefly discuss the pathophysiology of obesity and present the current pharmacotherapy for its treatment, focusing on orlistat, naltrexone/bupropion, liraglutide, and semaglutide. In addition, we briefly discuss upcoming pharmacotherapies for the management of obesity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
